Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2018 Oct 30

PMID 30371337

Citations 7

Authors

Allan D Sniderman

George Thanassoulis

John T Wilkins

Curt D Furberg

Michael Pencina

Affiliations

Soon will be listed here.

Citing Articles

Wildner M Gesundheitswesen. 2025; 87(1):17-20.

PMID: 39814014 PMC: 11740221. DOI: 10.1055/a-2419-8655.

More Drugs and Fewer Strokes? Time Trends in CVD Medication and Incidence of Stroke With German Health Insurance Data.

Mond L, Geyer S, Tetzlaff J, Weissenborn K, Schneider J, Epping J Pharmacoepidemiol Drug Saf. 2025; 34(1):e70077.

PMID: 39777935 PMC: 11706669. DOI: 10.1002/pds.70077.

Longitudinal metabolomics of increasing body-mass index and waist-hip ratio reveals two dynamic patterns of obesity pandemic.

Makinen V, Kettunen J, Lehtimaki T, Kahonen M, Viikari J, Perola M Int J Obes (Lond). 2023; 47(6):453-462.

PMID: 36823293 PMC: 10212764. DOI: 10.1038/s41366-023-01281-w.

Chronic Human Immunodeficiency Virus Infection Is Associated with Accelerated Decline of Forced Expiratory Volume in 1 Second among Women but Not among Men: A Longitudinal Cohort Study in Uganda.

McNeill J, Okello S, Sentongo R, Kakuhikire B, Tsai A, Christiani D Ann Am Thorac Soc. 2022; 19(10):1779-1783.

PMID: 35767026 PMC: 9753523. DOI: 10.1513/AnnalsATS.202111-1275RL.

Cross-sectional metabolic subgroups and 10-year follow-up of cardiometabolic multimorbidity in the UK Biobank.

Mulugeta A, Hypponen E, Ala-Korpela M, Makinen V Sci Rep. 2022; 12(1):8590.

PMID: 35597771 PMC: 9124207. DOI: 10.1038/s41598-022-12198-1.

References

Fulcher J, OConnell R, Voysey M, Emberson J, Blackwell L, Mihaylova B . Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015; 385(9976):1397-405. DOI: 10.1016/S0140-6736(14)61368-4. View

Cesena F, Laurinavicius A, Valente V, Conceicao R, Nasir K, Santos R . Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. Am J Cardiol. 2018; 121(11):1315-1320. DOI: 10.1016/j.amjcard.2018.02.011. View

Wang D, Hu F . Dietary Fat and Risk of Cardiovascular Disease: Recent Controversies and Advances. Annu Rev Nutr. 2017; 37:423-446. DOI: 10.1146/annurev-nutr-071816-064614. View

Verma A, Jimenez M, Subramanian S, Sniderman A, Razak F . Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circ Cardiovasc Qual Outcomes. 2017; 10(9). DOI: 10.1161/CIRCOUTCOMES.117.003764. View

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L . Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016; 388(10059):2532-2561. DOI: 10.1016/S0140-6736(16)31357-5. View

Chiolero A, Paradis G, Paccaud F . The pseudo-high-risk prevention strategy. Int J Epidemiol. 2015; 44(5):1469-73. DOI: 10.1093/ije/dyv102. View

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438):937-52. DOI: 10.1016/S0140-6736(04)17018-9. View

Ward Z, Long M, Resch S, Giles C, Cradock A, Gortmaker S . Simulation of Growth Trajectories of Childhood Obesity into Adulthood. N Engl J Med. 2017; 377(22):2145-2153. PMC: 9036858. DOI: 10.1056/NEJMoa1703860. View

Sniderman A, Thanassoulis G, Wilkins J, Furberg C, Pencina M . Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated. J Am Heart Assoc. 2018; 7(19):e010049. PMC: 6404899. DOI: 10.1161/JAHA.118.010049. View

10.

Pletcher M, Pignone M, Jarmul J, Moran A, Vittinghoff E, Newman T . Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease. J Am Heart Assoc. 2017; 6(2). PMC: 5523747. DOI: 10.1161/JAHA.116.004316. View

11.

Ahern J, Jones M, Bakshis E, Galea S . Revisiting rose: comparing the benefits and costs of population-wide and targeted interventions. Milbank Q. 2009; 86(4):581-600. PMC: 2614696. DOI: 10.1111/j.1468-0009.2008.00535.x. View

12.

Sniderman A, Thanassoulis G, Williams K, Pencina M . Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events. JAMA Cardiol. 2016; 1(4):492-4. DOI: 10.1001/jamacardio.2016.0991. View

13.

Ludwig D . Lowering the Bar on the Low-Fat Diet. JAMA. 2016; 316(20):2087-2088. DOI: 10.1001/jama.2016.15473. View

14.

Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes E . The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012; 380(9841):581-90. PMC: 3437972. DOI: 10.1016/S0140-6736(12)60367-5. View

15.

ODonnell M, Chin S, Rangarajan S, Xavier D, Liu L, Zhang H . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388(10046):761-75. DOI: 10.1016/S0140-6736(16)30506-2. View

16.

Pencina M, Navar-Boggan A, DAgostino Sr R, Williams K, Neely B, Sniderman A . Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014; 370(15):1422-31. DOI: 10.1056/NEJMoa1315665. View

17.

Rose G . Sick individuals and sick populations. Int J Epidemiol. 1985; 14(1):32-8. DOI: 10.1093/ije/14.1.32. View

18.

. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014; 384(9943):591-598. DOI: 10.1016/S0140-6736(14)61212-5. View

19.

Thanassoulis G, Pencina M, Sniderman A . The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017; 2(11):1175-1176. DOI: 10.1001/jamacardio.2017.2543. View

20.

Ford E, Li C, Sniderman A . Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988-1991 to 2005-2008. Cardiovasc Diabetol. 2013; 12:26. PMC: 3576331. DOI: 10.1186/1475-2840-12-26. View